Key words Kalopanaxsaponin-A; oral cancer; anti-invasive effect; metalloproteinase-9; HuR; Ras-associated binding 1AOral squamous cell carcinoma (OSCC) is a common malignant tumor in the oral and maxillofacial region, and it is the sixth most common cancer worldwide. In high-risk countries such as Sri Lanka, India, Pakistan, and Bangladesh, oral cancer may contribute up to 25% of all new cases of cancer, and in most countries, the five-year survival rates for cancers of the tongue, oral cavity and oropharynx are around 50%.
1)OSCC is characterized by a high degree of local invasiveness and a high rate of metastasis to the cervical lymph nodes.
2)Despite multidisciplinary treatment with surgery, chemotherapy and radiation, the overall survival rate has not improved significantly in patients with oral cancer. In addition, many patients who are successfully treated for oral cancer have to cope with devastating consequences in their appearance and function, including eating, drinking, swallowing and speaking.1) Consequently, controlling the invasiveness and metastasis of oral cancer represents an important therapeutic goal.OSCC progression is frequently associated with the acquisition of a more invasive phenotype and with proteinasedependent extracellular matrix (ECM) degradation.2) Invasive OSCC cells secrete matrix metalloproteinases (MMPs), which are mainly responsible for the degradation of environmental barriers such as ECM and the basement membrane. 3,4)